Literature DB >> 3611352

Activation of the human beta-globin promoter in K562 cells by DNA sequences 5' to the fetal gamma- or embryonic zeta-globin genes.

H J Lin, N P Anagnou, T R Rutherford, T Shimada, A W Nienhuis.   

Abstract

Regulatory sequences of the human fetal gamma-globin gene were studied by constructing composite gamma/beta globin promoters and comparing their function to that of intact beta promoters in human K562 cells. The beta-globin gene with either 1,600 or 127 basepairs of beta promoter sequence was not expressed after stable introduction into K562 cells, consistent with the known inactivity of the beta-globin gene in these cells. In contrast, a gamma/beta promoter composed of a gamma fragment spanning positions -408 to -137 joined to the 127-bp beta promoter was able to drive the beta-globin gene. The gene appeared to be inducible with hemin. A zeta-globin 5' flanking fragment also activated the beta promoter. The function of a series of composite gamma/beta promoters was then assessed by their ability to drive directly the neomycin resistance gene, again in stably transformed cells. The -408 to -137 gamma fragment activated the beta promoter in an orientation-specific manner in this assay. Deletion analysis showed that regulatory sequences were present between positions -259 and -137 of the fetal gamma-globin gene flanking region.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611352      PMCID: PMC442247          DOI: 10.1172/JCI113082

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

3.  K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin.

Authors:  T R Rutherford; J B Clegg; D J Weatherall
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

4.  Ribonucleic acid isolated by cesium chloride centrifugation.

Authors:  V Glisin; R Crkvenjakov; C Byus
Journal:  Biochemistry       Date:  1974-06-04       Impact factor: 3.162

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  RNA processing errors in patients with beta-thalassemia.

Authors:  T J Ley; N P Anagnou; G Pepe; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

7.  Differences in human alpha-, beta- and delta-globin gene expression in monkey kidney cells.

Authors:  R K Humphries; T Ley; P Turner; A D Moulton; A W Nienhuis
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

8.  Beta Thalassemia: mutations which affect processing of the beta-Globin mRNA precursor.

Authors:  J A Kantor; P H Turner; A W Nienhuis
Journal:  Cell       Date:  1980-08       Impact factor: 41.582

9.  Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).

Authors:  G Klein; J Zeuthen; I Eriksson; P Terasaki; M Bernoco; A Rosén; G Masucci; S Povey; R Ber
Journal:  J Natl Cancer Inst       Date:  1980-04       Impact factor: 13.506

10.  Embryonic erythroid differentiation in the human leukemic cell line K562.

Authors:  T Rutherford; J B Clegg; D R Higgs; R W Jones; J Thompson; D J Weatherall
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  11 in total

1.  Inducibility of the HS II enhancer depends on binding of an erythroid specific nuclear protein.

Authors:  P A Ney; B P Sorrentino; C H Lowrey; A W Nienhuis
Journal:  Nucleic Acids Res       Date:  1990-10-25       Impact factor: 16.971

2.  Functional erythroid promoters created by interaction of the transcription factor GATA-1 with CACCC and AP-1/NFE-2 elements.

Authors:  M Walters; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  Functional profile of the human fetal gamma-globin gene upstream promoter region.

Authors:  H J Lin; C Y Han; A W Nienhuis
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  Roles of fetal G gamma-globin promoter elements and the adult beta-globin 3' enhancer in the stage-specific expression of globin genes.

Authors:  C Perez-Stable; F Costantini
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

5.  A 46 base pair enhancer sequence within the locus activating region is required for induced expression of the gamma-globin gene during erythroid differentiation.

Authors:  B Sorrentino; P Ney; D Bodine; A W Nienhius
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

6.  Nuclear protein factors and erythroid transcription of the human A gamma-globin gene.

Authors:  F Catala; E deBoer; G Habets; F Grosveld
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

7.  A naturally occurring gamma globin gene mutation enhances SP1 binding activity.

Authors:  K Sykes; R Kaufman
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

8.  Enhancers increase the probability but not the level of gene expression.

Authors:  M C Walters; S Fiering; J Eidemiller; W Magis; M Groudine; D I Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

9.  Mutations in two regions upstream of the A gamma globin gene canonical promoter affect gene expression.

Authors:  J A Lloyd; R F Lee; J B Lingrel
Journal:  Nucleic Acids Res       Date:  1989-06-12       Impact factor: 16.971

10.  The human beta-globin gene contains multiple regulatory regions: identification of one promoter and two downstream enhancers.

Authors:  M Antoniou; E deBoer; G Habets; F Grosveld
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.